Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • The dual screen: Parallel genome-wide CRISPRi and CRISPRa screening
crrna-pools-appnote1920x640
Application Note

The dual screen: Parallel genome-wide CRISPRi and CRISPRa screening

Read this application note to learn how a dual screen using CRISPRi and CRISPRa gene modulation technologies in parallel allows for the identification of drug-gene interactions through paired gene perturbation analysis.

This combination approach offers researchers a novel, powerful and systematic way to explore drug mechanisms of action, identify novel bio-markers and provides compelling targets of use for the development of combination therapies.

For research use only. Not for use in diagnostic procedures.

Download Resource

The dual screen: Parallel genome-wide CRISPRi and CRISPRa screening

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.